The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Breast Neoplasms
  • Central Nervous System Neoplasms

abstract

  • Despite the impression of many oncologists, the results of this study did not support an association between trastuzumab therapy and an increased risk of CNS metastases.

publication date

  • August 15, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.20418

PubMed ID

  • 15305414

Additional Document Info

start page

  • 810

end page

  • 6

volume

  • 101

number

  • 4